Growth hormone signal transduction

Journal of Pediatric Endocrinology and Metabolism

Volumn 15, Issue 6, 2002, Pages 771-786

  Piwien Pilipuk, Graciela ^a   Huo, Jeffrey S ^a   Schwartz, Jessica ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cytokine receptor family; Gene transcription; GH receptor; JAK2; MAPK; PI3K; SOCS CIS; STATs; Tyrosine kinase; Tyrosine phosphatase

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; STAT PROTEIN; DNA BINDING PROTEIN; HUMAN GROWTH HORMONE; INSULIN RECEPTOR; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; MILK PROTEIN; ONCOPROTEIN; SOMATOMEDIN C; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

CONTROLLED STUDY; GENE CONTROL; GROWTH REGULATION; HUMAN; METABOLIC REGULATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; LIVER; METABOLISM; PANCREAS ISLET; PHYSIOLOGY; PROMOTER REGION; SEXUAL DEVELOPMENT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; ISLETS OF LANGERHANS; JANUS KINASE 2; LIVER; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, INSULIN; RECEPTORS, SOMATOTROPIN; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0035986365     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2002.15.6.771     Document Type: Review

References (179)

1. Growth hormone stimulates longitudinal bone growth directly
2. Treatment of a pituitary dwarf with human growth hormone
3. Body composition in hypopituitary dwarfs before and during human growth hormone therapy
4. Effect of growth hormone on cell and somatic growth
5. Body composition in acromegaly
6. Molecular events in growth hormone-receptor interaction and signalling
7. Structural design and molecular evolution of a cytokine receptor superfamily
8. Cytokine receptor signal transduction and the control of hematopoietic cell development
9. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule
10. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex
11. Receptor dimerization in GH and erythropoietin action - It takes two to tango, but how?
12. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
13. Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes
14. Evidence for involvement of the growth hormone receptor-associated tyrosine kinase in actions of growth hormone
15. Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinase in cells transfected with rat GH receptor cDNA
16. Stimulation of tyrosine phosphorylation in human cells by activation of the growth hormone receptor
17. Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins
18. Growth hormone receptor and serum binding protein: Purification, cloning and expression
19. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase
20. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells
21. Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes
22. Identification of SH2-Bβ as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling
23. Identification of SH2-Bβ as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2
24. SH2-Bβ is a Rac-binding protein that regulates cell motility
25. SH2-B is required for nerve growth factor-induced neuronal differentiation
26. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
27. STATs: Signal Transducers and Activators of Transcription
28. The role of STAT proteins in growth hormone signaling
29. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor
30. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone
31. Growth hormone-induced tyrosyl phosphorylation and DNA binding activity of Stat5A and Stat5B
32. Nuclear actions of growth hormone: Rapid tyrosine phosphorylation and activation of Stat1 and Stat3 after in vivo growth hormone treatment
33. Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites
34. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation
35. Identification of a growth hormone responsive Stat 5-binding element in the rat insulin 1 gene
36. A STAT factor mediates the sexually dimorphic regulation of hepatic cytochrome P450 3A10/lithocholic acid 6 beta-hydroxylase gene expression by growth hormone
37. Growth hormone induces insulin-like growth factor-I gene transcription by a synergistic action of STAT5 and HNF-1α
38. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5)
39. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein
40. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation
41. STAT5b is required for GH-induced liver IGF-I gene expression
42. The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of Stat 3
43. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
44. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway
45. Mitogen-activated protein kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5
46. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins
47. Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a
48. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
49. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
50. Stat5a is mandatory for adult mammary gland development and lactogenesis
51. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
52. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
53. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron syndrome children
54. A completely foreign receptor can mediate an interferon-γ-like response
55. How MAP kinases are regulated
56. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers
57. Signal transduction through MAP kinase cascades
58. Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone. Resultant transcriptional activation of ATF-2 and CHOP, cytoskeletal re-organization and mitogenesis
59. Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts
60. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation
61. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes
62. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II
63. Simultaneous activation of p90rsk and p70s6k S6 kinases by growth hormone in 3T3-F442A preadipocytes
64. Growth hormone stimulates phosphorylation and activation of Elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2
65. Growth hormone regulates Ternary Complex Factors and Serum Response Factor associated with the c-fos Serum Response Element
66. Growth hormone (GH) induces the formation of protein complexes involving Stat5, Erk2, Shc and serine phosphorylated proteins
67. Effect of growth hormone on carbohydrate and lipid metabolism
68. Growth hormone, interferon-γ and leukemia inhibitory factor promote tyrosyl phosphorylation of insulin receptor substrate-1
69. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling
70. Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1
71. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes
72. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase kinase
73. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling
74. Lipid-regulated kinases: Some common themes at last
75. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B
76. Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site
77. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
78. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades
79. Mechanisms and consequences of activation of protein kinase B/Akt
80. PI-3′ kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes
81. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways
82. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes
83. Studies with wortmannin suggest a role for phosphatidylinositol 3-kinase in the activation of glycogen synthase and mitogen-activated protein kinase by insulin in rat adipocytes: Comparison of insulin and protein kinase C modulators
84. Differential effects of wortmannin on growth hormone dependent signalling pathways in 3T3-F442A cells
85. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation
86. CrkII participation in the cellular effects of growth hormone and insulin-like growth factor-1. Phosphatidylinositol-3 kinase dependent and independent effects
87. Growth hormone regulates phosphorylation and function of C/EBP beta by modulating Akt and glycogen synthase kinase-3
88. LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-1 gene in rat hepatocytes
89. Protein kinase C - A question of specificity
90. Regulation of protein kinase C
91. Role of kinase C in the insulin-like effects of human growth hormone in rat adipocytes
92. Transcriptional control of the expression of lipoprotein lipase gene by growth hormone in preadipocyte Ob1771 cells
93. Growth hormone stimulates c-fos gene expression by means of protein kinase C without increasing inositol lipid turnover
94. Growth hormone increases calcium uptake in rat fat cells by a mechanism dependent on protein kinase C
95. 2+ influx and diacylglycerol synthesis in growth hormone-mediated islet beta-cell mitogenesis
96. Platelet-derived growth factor and lysophosphatidic acid inhibit growth hormone binding and signaling via a protein kinase C-dependent pathway
97. Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: Relationship to GH receptor down-regulation
98. 2+ oscillations and gene transcription
99. Growth hormone increases intracellular free calcium in rat adipocytes: Correlation with actions on carbohydrate metabolism
100. Growth hormone regulates cytosolic free calcium in rat fat cells by maintaining L-type calcium channels
101. A dual effector theory of growth hormone action
102. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo
103. Mode of action of pituitary growth hormone on target cells
104. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans
105. Mice deficient in liver production of insulin-like growth factor I display sexual dimorphism in growth hormone-stimulated postnatal growth
106. Regulation of insulin-like growth factor I gene expression by growth hormone
107. Tissue concentrations of somatomedin C: Further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action
108. Rapid activation of rat insulin-like growth factor-I gene transcription by growth hormone reveals no changes in deoxyribonucleic acid-protein interactions within the second promoter
109. Characterization of deoxyribonucleic acid-protein interactions at a growth hormone-inducible nuclease hypersensitive site in the rat insulin-like growth factor-I gene
110. Growth hormone-mediated regulation of insulin-like growth factor I promoter activity in C6 glioma cells
111. Insulin-like growth factors: Gene structure and regulation
112. Growth hormone suppression of insulin-like growth factor binding protein-1 promoter activity
113. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells
114. An inducible nuclear factor binds to a growth hormone-regulated gene
115. Growth hormone induces two mRNA species of the serine protease inhibitor gene family in rat liver
116. Study of a growth hormone-regulated protein secreted by rat hepatocytes: cDNA cloning, anti-protease activity and regulation of its synthesis by various hormones
117. Regulation of two rat serine-protease inhibitor gene promoters by somatotropin and glucocorticoids. Study with intact hepatocytes and cell-free systems
118. The growth hormone dependent serine protease inhibitor, Spi 2.1 inhibits the des (1-3) insulin-like growth factor-I generating protease
119. Growth hormone specifically regulates serine protease inhibitor gene transcription via gamma-activated sequence-like DNA elements
120. Binding of a growth hormone-inducible nuclear factor is mediated by tyrosine phosphorylation
121. Yin-yang 1 and glucocorticoid receptor participate in the Stat5-mediated growth hormone response of the serine protease inhibitor 2.1 gene
122. Everything you have ever wanted to know about Yin Yang 1
123. Analysis of proteins binding to the proximal promoter region of two rat serine protease inhibitor genes
124. A novel growth hormone response element unrelated to STAT (signal transducer and activator of transcription)-binding sites is a bifunctional enhancer
125. Male-specific transcription initiation of the C4-Slp gene in mouse liver follows activation of STAT5
126. Cooperative regulation of CYP2C12 gene expression by STAT5 and liver-specific factors in female rats
127. Gender differences in drug metabolism regulated by growth hormone
128. Induction of prolactin receptors in rat liver after the administration of growth hormone
129. Growth hormone pretranslationally regulates the sexually dimorphic expression of the prolactin receptor gene in rat liver
130. Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice
131. Expression of hepatocyte nuclear factor 6 in rat liver is sex-dependent and regulated by growth hormone
132. Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone
133. Inhibitory cross-talk between STAT5b and Liver Nuclear Factor HNF3 beta
134. Introduction of exogenous growth hormone receptors augments growth hormone-responsive insulin biosynthesis in rat insulinoma cells
135. Growth hormone binding to specific receptors stimulates growth and function of cloned insulin-producing rat insulinoma RIN-5AH cells
136. Rapid events in growth hormone action. Induction of c-fos and c-jun transcription in 3T3-F442A preadipocytes
137. The regulation by growth hormone of lipoprotein lipase gene expression is mediated by c-fos protooncogene
138. Growth hormone induces expression of c-jun and junB oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos gene expression
139. Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo
140. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue
141. Growth hormone and colony-stimulating factor 1 share multiple response elements in the c-fos promoter
142. Rapid changes in gene expression after in vivo growth hormone treatment
143. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor
144. The serum response element can mediate induction of c-fos by growth hormone
145. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA binding activity
146. The carboxyl-terminal transactivation domain of human serum response factor contains DNA-activated protein kinase phosphorylation sites
147. cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription
148. The helix-loop-helix protein rE12 and the C/EBP-related factor rNFIL-6 bind to neighboring sites within the c-fos serum response element
149. CCAAT/enhancer-binding protein beta (C/EBP beta) and C/EBPδ contribute to growth hormone-regulated transcription of c-fos
150. TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
151. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines
152. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
153. Growth hormone-binding proteins: State of the art
154. Blockade of growth hormone receptor shedding by a metalloprotease inhibitor
155. Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis
156. Intracellular processing of growth hormone receptors by adipocytes in primary culture
157. Linkage of the ubiquitin-conjugating system and the endocytic pathway in ligand-induced internalization of the growth hormone receptor
158. Endocytosis and degradation of the growth hormone receptor are proteasome-dependent
159. Growth hormone-induced signal transduction depends on an intact ubiquitin system
160. The signal transduction of the growth hormone receptor is regulated by the ubiquitin/proteasome system and continues after endocytosis
161. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation
162. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase
163. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins
164. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling
165. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B
166. Potentiation of growth hormone-induced liver suppressors of cytokine signaling messenger ribonucleic acid by cytokines
167. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
168. Stat5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver
169. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms
170. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone
171. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
172. The suppressors of cytokine signaling (SOCS) proteins: Important feedback inhibitors of cytokine action
173. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance
174. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo
175. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia
176. Identification of genes induced by growth hormone in rat liver using cDNA arrays
177. Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat
178. CCAAT/enhancer-binding protein-alpha is a component of the growth hormone-regulated network of liver transcription factors
179. Growth hormone prevents apoptosis through activation of nuclear factor-kappaB in interleukin-3-dependent Ba/F3 cell line